Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 9;13:2103–2114. doi: 10.2147/OTT.S233149

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Xing et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

LncRNA PVT1 links UPF1. (A) PVT1 expression is examined by RT-PCR, with GAPDH expression as normalization. (B) Association between expression levels of UPF1 and PVT1 RNAs in 24 EC tissues. (C) Actinomycin D is employed for cell treatment for the denoted time, and RT-PCR is implemented for the assessment of PVT1 RNA level. (D) RIP test denotes the linkage between UPF1 and PVT1. (E) UPF1 overexpression reduces PVT1 expression. HEC1A cells are treated with UPF1 plasmid. (F) UPF1 decrement in HEC1A cells raises PVT1 expression. (*P<0.05).